ArticleScientific reports2025
Analysis of the risk of metachronous colorectal cancer and long-term prognosis in patients following gastrectomy for gastric cancer.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Risk assessment of secondary primary malignancies: results from two large prospective European cohorts.NPJ precision oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The impact of gastrectomy on the risk of developing second colorectal cancer (SCRC) in gastric cancer patients remains unclear. This study aimed to evaluate the association between gastrectomy and SCRC in gastric cancer patients. A total of 17,606 patients with gastric cancer were identified from the SEER database and categorized into gastrectomy (GT) and non-gastrectomy (NGT) groups. Fine-Gray competing risk analysis was employed to calculate the cumulative incidence of SCRC in different groups. Competing risk analysis and Poisson regression were used to assess the association between gastrectomy and SCRC risk. Standardized incidence ratios (SIRs) were calculated to compare CRC incidence in the GT and NGT groups with that in the general US population. A total of 128 patients in the GT group (0.8%) and 9 patients in the NGT group (0.4%) developed SCRC. Gastrectomy was identified as a significant adverse factor in both univariate and multivariate Poisson regression analyses. SIRs revealed a higher CRC incidence in the GT group compared to the general population, while the NGT group showed no significant difference. Gastrectomy is associated with an increased risk of SCRC in gastric cancer patients and significantly improves survival in those who develop SCRC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.